Sanofi angles to buy Kiadis for €308 million
November 2, 2020Sales and Marketing Sanofi, kiadis, pharma
Sanofi has announced it is poised to buy out Amsterdam-based biopharma firm Kiadis in an all-cash public offer of €308 …
LEO Pharma’s delgocitinib hits main goals in moderate-to-severe chronic hand eczema
November 2, 2020Research and Development, Sales and Marketing LEO Pharma, eczema, pharma
LEO Pharma has revealed new Phase 2b at the European Academy of Dermatology and Venereology (EADV) Virtual 2020 Virtual Congress …
Parag Agarwal appointed as Dr Reddy’s Laboratories Chief Financial Officer
October 30, 2020Sales and Marketing
Dr Reddy’s Laboratories has appointed Parag Agarwal has the company’s new Chief Financial Officer. Parag has a career that spans …
NICE recommends Novo’s liraglutide for management of obesity and non-diabetic hyperglycaemia
October 30, 2020Medical Communications, Sales and Marketing NICE, Novo Nordisk, liraglutide
Novo Nordisk’s pre-filled injection Saxenda (liraglutide) has received the backing of drug watchdog NICE, meaning it will now be made …
AstraZeneca jettisons two heart drugs to Cheplapharm in $400m deal
October 30, 2020Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Cheplapharm
AstraZeneca is set to sell the rights to its AT1 subtype angiotensin II receptor antagonist Atacand (candesartan cilexetil) and Atacand …
EU approves Zejula as a first-line monotherapy maintenance treatment in advanced ovarian cancer
October 30, 2020Medical Communications
The European Commission has approved GlaxoSmithKline’s Zeljula as a first line monotherapy maintenance treatment for adult patients with ovarian cancer …
New study suggests UK Government’s ‘Eat Out to Help Out’ scheme increased coronavirus infection rates
October 30, 2020Medical Communications
The Eat Out to Help Out scheme contributed to a significant rise in new coronavirus cases according to a study …
Top Ten most popular articles on Pharmafile.com this week
October 30, 2020Medical Communications
The top ten news stories this week focus on COVID-19 studies, as new research has found that over 80% of …
David Woodward joins GAMA Healthcare as Board Business Advisory Consultant and CEO Mentor
October 29, 2020Business Services
GAMA Healthcare have announced that David Woodward has been brought on as Board Business Advisory Consultant and CEO Mentor. Woodward …
European Commission greenlights Insmed’s Arikayce for nontuberculous mycobacterial lung infections
October 29, 2020Sales and Marketing Arikayce, EU, lungs, pharma
The European Commission (EC) has given approval to Insmed Incorporated’s Arikayce (liposomal 590mg nebuliser dispersion) for the treatment of nontuberculous …
NICE says test people with womb cancer for Lynch syndrome
October 29, 2020Medical Communications
New guidance from the National Institute of Health and Care Excellence says that women with womb cancer should be tested …
Nearly 100,000 people catching coronavirus every day in England, new study suggests
October 29, 2020Research and Development
Nearly 100,000 people are being infected with COVID-19 each day according to a new study from Imperial College London. Named …
FDA approves Sanofi’s ivermectin head lice treatment for over-the-counter use
October 29, 2020Sales and Marketing
The FDA has approved Sanofi’s Sklice (ivermectin) for over-the-counter use. Sklice is a single-use lotion that includes ivermectin 0.5% as …
Takeda commits to deliver 50 million doses of Moderna’s COVID-19 vaccine in Japan
October 29, 2020Manufacturing and Production, Sales and Marketing COVID-19, Japan, Moderna, Takeda, Vaccine
Takeda has made a commitment with Japan’s Ministry of Health, Labor and Welfare (MHLW) to deliver 50 million doses of …
Redx Pharma appoints Dr Jane Robertson as Chief Medical Officer
October 29, 2020Research and Development
Redx Pharma has announced the appointment of Dr Jane Robertson as its new Chief Medical Officer at the company. Robertson …
GSK and Sanofi promise 200m COVID-19 vaccines to international COVAX initiative
October 28, 2020Manufacturing and Production, Research and Development COVAX, COVID-19, GSK, Sanofi
Sanofi and GSK have committed 200 million doses of their adjuvanted recombinant protein-based COVID-19 vaccine to the COVAX Facility, a …
Novartis collaborates with Molecular Partners to develop therapies to use against COVID-19
October 28, 2020Research and Development
Novartis and Molecular Partners AG have announced that they will develop, commercialise and manufacture Molecular’s anti-COVID-19 DARPin programme, which consists …
US reserves 300,000 doses of Lilly’s COVID-19 treatment in $375 million deal
October 28, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Eli Lilly, US, pharma
The US Government has signed a $375 million deal with Eli Lilly to buy 300,000 700mg doses of bamlanivimab, its …
80% of COVID-19 patients in study were vitamin D-deficient
October 28, 2020Research and Development
New research has found that over 80% of COVID-19 patients in a recent study had a vitamin D deficiency. The …
Pharmafile.com’s weekly COVID-19 news round-up
October 28, 2020Research and Development
The coronavirus news this week focuses on clinical trials testing potential vaccines, with the University of Oxford and AstraZeneca stating …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
